image315

An Innovest Global Inc. Company Stock Symbol: IVST

Translational Biotechnology Company Developing Novel Immunotherapies for Brain Tumor Patients 

COVID-19

As COVID-19 impacts the world, StemVax Therapeutics continues to be committed to making a difference in brain cancer patients' lives by maintaining focus on developing a highly effective vaccine for Glioblastoma (GBM). We are also committed to working hard to support all healthcare professionals, patients, and communities here in the U.S. and globally. We are learning so much more about COVID-19 recently than ever before. We seek to utilize our expertise to participate in the development of novel diagnostic and therapeutic tools to address COVID-19 and other viruses that contribute to seasonal flu outbreaks.

image316
image317

Cutting-Edge Research & Creativity to Face the Unknown

Cutting-Edge Research & Creativity to Face the Unknown

Cutting-Edge Research & Creativity to Face the Unknown

image318

Keeping Dreams Alive Through Immunotherapy

Cutting-Edge Research & Creativity to Face the Unknown

Cutting-Edge Research & Creativity to Face the Unknown

image319

Treating Disease with Stem Cell Immunology

Cutting-Edge Research & Creativity to Face the Unknown

Treating Disease with Stem Cell Immunology

Subscribe

Our Partners

image320

Awards

image321